| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on Mobiquity Technologies, Inc.|
Txns:
| Granted 130,000 shares
@ $0.167, valued at
$21.7k
|
|
| 03/10/2023 |
SC 13G/A
| Salkind Gene reports a 13.6% stake in UPEXI, INC. |
| 01/31/2023 |
4
| Salkind Gene (Director) has filed a Form 4 on Coeptis Therapeutics Holdings, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2022 |
3
| Salkind Gene (Director) has filed a Form 3 on Coeptis Therapeutics Holdings, Inc. |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on GROVE, INC.|
Txns:
| Bought 125,000 shares
@ $4, valued at
$500k
|
|
| 03/31/2022 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on Mobiquity Technologies, Inc.|
Txns:
| Converted 1,368,333 shares
@ $1.5, valued at
$2.1M
Converted options to buy
@ $1.5, valued at
$0
Converted 684,166 options to buy
@ $4, valued at
$2.7M
|
|
| 02/14/2022 |
SC 13G
| Salkind Gene reports a 14.6% stake in Grove, Inc. |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on GROVE, INC.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 06/24/2021 |
3
| Salkind Gene (10% Owner) has filed a Form 3 on GROVE, INC. |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Salkind Gene (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 6,000 shares
@ $0 |
|
| 01/21/2020 |
4/A
| Salkind Gene (10% Owner) has filed a Form 4 on Mobiquity Technologies, Inc.|
Txns:
| Bought 35,000,000 shares
@ $0.0096, valued at
$336k
Bought 127,500,000 shares
@ $0.0185, valued at
$2.4M
Bought 12,500,000 shares
@ $0.04, valued at
$500k
Granted 2,300,000 notes
@ $0.08, valued at
$184k
|
|
| 01/03/2020 |
4
| Salkind Gene (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Exercised 7,593 restricted stock units
@ $0 |
|
| 09/19/2019 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on Mobiquity Technologies, Inc.|
Txns:
| Bought 35,000,000 shares
@ $0.0096, valued at
$336k
Bought 127,500,000 shares
@ $0.0185, valued at
$2.4M
Bought 12,500,000 shares
@ $0.04, valued at
$500k
Granted 2,300,000 notes
@ $0.08, valued at
$184k
|
|
| 09/09/2019 |
3
| Salkind Gene (Director) has filed a Form 3 on DermTech, Inc. |
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2019 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on Mobiquity Technologies, Inc.|
Txns:
| Granted 6,875,000 shares
@ $0.08, valued at
$550k
Granted 3,437,500 warrants
@ $0.12, valued at
$412.5k
|
|
| 04/04/2019 |
4
| Salkind Gene (10% Owner) has filed a Form 4 on Mobiquity Technologies, Inc.|
Txns:
| Granted 12,500,000 shares
@ $0.08, valued at
$1M
Granted 6,250,000 warrants
@ $0.12, valued at
$750k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |